| scholarly article | Q13442814 |
| P356 | DOI | 10.1053/JLTS.2003.50243 |
| P953 | full work available at URL | https://onlinelibrary.wiley.com/doi/pdfdirect/10.1053/jlts.2003.50243 |
| https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1053%2Fjlts.2003.50243 | ||
| https://onlinelibrary.wiley.com/doi/full/10.1053/jlts.2003.50243 | ||
| P698 | PubMed publication ID | 14586894 |
| P5875 | ResearchGate publication ID | 9033319 |
| P50 | author | Marina Berenguer Haym | Q65161967 |
| P2860 | cites work | Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups | Q29614459 |
| Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis | Q29619508 | ||
| The use of hepatitis C-infected grafts in liver transplantation | Q35572059 | ||
| The role of immunosuppression in recurrence of hepatitis C. | Q35572068 | ||
| Histology predicts cirrhotic evolution of post transplant hepatitis C | Q35594584 | ||
| Advancing donor liver age and rapid fibrosis progression following transplantation for hepatitis C | Q35594900 | ||
| Donor polymorphism of tumor necrosis factor gene: relationship with variable severity of hepatitis C recurrence after liver transplantation | Q38466212 | ||
| Slowly tapering off steroids protects the graft against hepatitis C recurrence after liver transplantation | Q40629465 | ||
| The influence of HLA donor-recipient compatibility on the recurrence of HBV and HCV hepatitis after liver transplantation | Q41450518 | ||
| HCV-related fibrosis progression following liver transplantation: increase in recent years | Q41732518 | ||
| The outcome of liver grafts procured from hepatitis C-positive donors | Q42671965 | ||
| The association between hepatitis C infection and survival after orthotopic liver transplantation | Q42672810 | ||
| Histological and clinical outcome after liver transplantation for hepatitis C. | Q42985828 | ||
| The influence of hepatitis C virus genotypes on the outcome of liver transplantation | Q42986493 | ||
| Early development of chronic active hepatitis in recurrent hepatitis C virus infection after liver transplantation: association with treatment of rejection. | Q42988520 | ||
| Predictors of patient and graft survival following liver transplantation for hepatitis C. | Q42989860 | ||
| High incidence of allograft cirrhosis in hepatitis C virus genotype 1b infection following transplantation: relationship with rejection episodes. | Q42991412 | ||
| European collaborative study on factors influencing outcome after liver transplantation for hepatitis C. European Concerted Action on Viral Hepatitis (EUROHEP) Group. | Q42994900 | ||
| Early identification of recipients with progressive histologic recurrence of hepatitis C after liver transplantation | Q43000722 | ||
| Long-term outcome of hepatitis C infection after liver transplantation | Q43046814 | ||
| Contribution of donor age to the recent decrease in patient survival among HCV-infected liver transplant recipients. | Q43519797 | ||
| Are posttransplantation protocol liver biopsies useful in the long term? | Q43734162 | ||
| Anti-interleukin-2 receptor therapy in combination with mycophenolate mofetil is associated with more severe hepatitis C recurrence after liver transplantation. | Q43831138 | ||
| Timing and severity of initial hepatitis C recurrence as predictors of long-term liver allograft injury | Q44213614 | ||
| Natural history of clinically compensated hepatitis C virus-related graft cirrhosis after liver transplantation | Q45740469 | ||
| Liver transplantation in adults coinfected with HIV. | Q45881728 | ||
| Hepatocellular carcinoma: Can it be considered a controversial indication for liver transplantation in centers with high rates of hepatitis C? | Q62618857 | ||
| Liver transplantation for hepatitis C: recurrence and disease progression in 300 patients | Q74296454 | ||
| Hepatitis C and liver transplantation | Q77110599 | ||
| Natural history of recurrent hepatitis C | Q78321473 | ||
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | liver transplantation | Q1368191 |
| surgery | Q40821 | ||
| P304 | page(s) | S44-7 | |
| P577 | publication date | 2003-11-01 | |
| P1433 | published in | Liver Transplantation | Q15730498 |
| P1476 | title | Host and donor risk factors before and after liver transplantation that impact HCV recurrence | |
| P478 | volume | 9 |
| Q45458534 | Amantadine monotherapy is ineffective in the treatment of hepatitis C virus recurrence in the post-liver transplantation setting. |
| Q39887907 | Antihepatitis C virus therapy in liver transplanted patients |
| Q46682644 | Antithymocyte globulin induction therapy in hepatitis C-positive liver transplant recipients |
| Q35915073 | Association of genetic variants with rapid fibrosis: progression after liver transplantation for hepatitis C. |
| Q52934767 | C4d in acute rejection after liver transplantation--a valuable tool in differential diagnosis to hepatitis C recurrence. |
| Q44698568 | Cholestatic hepatitis C following liver transplantation: an outcome-based histological definition, clinical predictors, and prognosis |
| Q22299427 | Current management and perspectives for HCV recurrence after liver transplantation |
| Q39968802 | Digital image analysis of liver collagen predicts clinical outcome of recurrent hepatitis C virus 1 year after liver transplantation |
| Q42997805 | ELISA-based detection of C4d after liver transplantation--a helpful tool for differential diagnosis between acute rejection and HCV-recurrence? |
| Q39911623 | Efficacy and safety of sofosbuvir/ledipasvir for the treatment of patients with hepatitis C virus re-infection after liver transplantation |
| Q42220066 | Graft and viral outcomes in retransplantation for hepatitis C virus recurrence and HCV primary liver transplantation: a case-control study |
| Q42982631 | HCV in liver transplantation |
| Q82639897 | Hepatic venous pressure gradient identifies patients at risk of severe hepatitis C recurrence after liver transplantation |
| Q26781984 | Hepatitis C Recurrence after Orthotopic Liver Transplantation: Mechanisms and Management |
| Q51696215 | Hepatitis C infection and survivals of liver transplant patients in Canada, 1997-2003. |
| Q36652081 | Hepatitis C virus re-infection: new perspectives |
| Q44199668 | Hepatocellular carcinoma in unrelated viral cirrhosis: long-term results after liver transplantation |
| Q37970381 | Immunosuppression, liver injury and post-transplant HCV recurrence |
| Q37314134 | Indications for liver transplantation in adults : Recommendations of the Austrian Society for Gastroenterology and Hepatology (ÖGGH) in cooperation with the Austrian Society for Transplantation, Transfusion and Genetics (ATX). |
| Q45388680 | Influence of donor age on survival in liver transplantation due to hepatitis C virus. |
| Q26781331 | Interferon-Free Hepatitis C Treatment before and after Liver Transplantation: The Role of HCV Drug Resistance |
| Q36027124 | Liver transplantation for viral hepatitis |
| Q36579539 | Liver transplantation organ allocation between Child and MELD. |
| Q38174249 | Management of HCV transplant patients with triple therapy |
| Q26781741 | Management of Hepatitis C Post-liver Transplantation: a Comprehensive Review |
| Q38395275 | Management of post transplant hepatitis C in the direct antiviral agents era. |
| Q34718623 | Management practices of hepatitis C virus infected alcoholic hepatitis patients: A survey of physicians |
| Q42991028 | Minimization of immunosuppression with thymoglobuline pre-treatment and HCV recurrence in liver transplantation |
| Q30733177 | Pegylated IFN-α and ribavirin: emerging data in the treatment of special populations |
| Q40434282 | Predictors of Poor Prognosis in Recurrent Hepatitis C After Liver Transplantation |
| Q37628365 | Predictors of disease recurrence post living donor liver transplantation in end stage chronic HCV patients. |
| Q42992322 | Randomized, multicenter trial comparing tacrolimus plus mycophenolate mofetil to tacrolimus plus steroids in hepatitis C virus-positive recipients of living donor liver transplantation. |
| Q38229320 | Recurrent HCV after liver transplantation-mechanisms, assessment and therapy |
| Q36001720 | Retracted: Pathological Roles of Interleukin-22 in the Development of Recurrent Hepatitis C after Liver Transplantation |
| Q37973516 | Spanish society of liver transplantation (SETH) consensus recommendations on hepatitis C virus and liver transplantation. |
| Q42230188 | Telaprevir drug monitoring during antiviral therapy of hepatitis C graft infection after liver transplantation |
| Q57791877 | The Tor Vergata weaning off immunosuppression protocol in stable HCV liver transplant patients: The updated follow up at 78 months |
| Q46763263 | The impact of donor variables on the outcome of orthotopic liver transplantation for hepatitis C. |
| Q35572048 | The natural history and outcome of liver transplantation in hepatitis C virus-infected recipients |
| Q45385243 | Treatment for recurrent hepatitis C virus infection after liver transplantation |
Search more.